
A JAMA study of nearly 25,000 vitiligo patients reveals major gaps in real-world treatment duration and consistency.

Genevieve Gauthier, MSc, serves as a senior director and Real-World Evidence (RWE) Scientist for Inflammation and Immunology at Pfizer.

A JAMA study of nearly 25,000 vitiligo patients reveals major gaps in real-world treatment duration and consistency.